Page last updated: 2024-09-04

methanearsonous acid and Leukemia, Promyelocytic, Acute

methanearsonous acid has been researched along with Leukemia, Promyelocytic, Acute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Gao, C; Hai, X; Li, J; Lin, L; Lv, J; Tian, S; Wu, M1
Bu, N; Cao, FL; Naranmandura, H; Wang, QQ; Zhang, YF; Zhou, J; Zhou, XY1
Carew, MW; Hao, WH; Le, XC; Loo, JF; Naranmandura, H; Xu, S; Zhang, YF1

Other Studies

3 other study(ies) available for methanearsonous acid and Leukemia, Promyelocytic, Acute

ArticleYear
Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Toxicology letters, 2023, May-01, Volume: 380

    Topics: Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Hemoglobins; Humans; Leukemia, Promyelocytic, Acute; Oxides

2023
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Oncotarget, 2015, Sep-22, Volume: 6, Issue:28

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Methylation; Nuclear Proteins; Oncogene Proteins, Fusion; Organometallic Compounds; Oxides; Promyelocytic Leukemia Protein; Proteasome Endopeptidase Complex; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Sumoylation; Time Factors; Transcription Factors; Tumor Suppressor Proteins

2015
Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.
    Archives of toxicology, 2013, Volume: 87, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenites; Biotransformation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Organometallic Compounds; Propionates; Quinolines; Sodium Compounds

2013